RET fusion in advanced non-small-cell lung cancer and response to cabozantinib: A case report

RATIONALE: Lung cancer is a series of gene-driven disease. EGFR, ALK, and ROS1 are 3 major driver genes that play an important role in lung cancer development and precision management. Additionally, rare genetic alterations continue to be discovered and may become novel targets for therapy. The RET...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yucong, Xu, Yinghui, Wang, Xu, Sun, Chao, Guo, Ye, Shao, Guoguang, Yang, Zhiguang, Qiu, Shi, Ma, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370068/
https://www.ncbi.nlm.nih.gov/pubmed/30653139
http://dx.doi.org/10.1097/MD.0000000000014120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370068/
https://www.ncbi.nlm.nih.gov/pubmed/30653139
http://dx.doi.org/10.1097/MD.0000000000014120

Ejemplares similares